| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Revenue | $2.46B | +3.5% |
| Cost of Revenue | $2.09B | +0.5% |
| Gross Profit | $369.8M | +24.4% |
| R&D Expense | $5.8M | +75.8% |
| SG&A Expense | $187.6M | -0.6% |
| Operating Income | $182.2M | +128.9% |
| Interest Expense | $25.1M | -11.9% |
| Pre-tax Income | $117.5M | -65.5% |
| Income Tax | $22.3M | -73.1% |
| Net Income | $95.2M | -63.0% |
| EPS (Basic) | $1.92 | -59.9% |
| EPS (Diluted) | $1.89 | -60.0% |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.7M | +41.1% |
| Accounts Receivable | $167.6M | +10.0% |
| Inventory | $527.1M | -12.6% |
| Current Assets | $777.7M | -3.6% |
| Total Assets | $1.20B | -1.1% |
| Current Liabilities | $515.3M | +9.8% |
| Long-term Debt | $40.0M | -52.9% |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $241.1M | +351.5% |
| Capital Expenditures | $51.1M | +85.1% |
| Investing Cash Flow | -$50.3M | -114.4% |
| Financing Cash Flow | -$180.7M | +54.7% |
| Free Cash Flow | $190.0M | +636.4% |
| Total Liabilities |
| $783.7M |
| +0.7% |
| Stockholders' Equity | $416.3M | -4.3% |